ArticleHuman vaccines & immunotherapeutics2026
Reduced T cell epitope cross-conservation and immunogenic potential is associated with emergence of a dominant influenza subclade K in 2025.
Article in Human vaccines & immunotherapeutics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Subclade K is a newly emergent influenza A/H3N2 strain that became the dominant strain circulating globally; more than 90% of influenza A virus (IAV) cases in 2025-26 were subclade K. While seasonal vaccines elicited measurable cross-reactive hemagglutination inhibition (HI) and neutralizing antibody responses against the new strain were deemed to be protective, T cells contribute substantially to protection against infection and severe disease. T cell epitopes that are conserved between vaccine strains and circulating strains may have a protective effect. We hypothesized that mutations in the HA antigen introduced by viral evolution resulted in the loss of some cross-conserved T cell epitopes and that this loss may have contributed to the emergence of subclade K. Using a new immunoinformatics tool, EpiCC, we assessed T cell epitope cross-conservation between subclade K, other circulating H3N2 strains, and the most recent seasonal vaccine strains. Evaluation of 706 H3N2 HA sequences demonstrated a 10% reduction in cross-conserved T cell epitope content between seasonal vaccines, circulating strains and subclade K. Decreased cross-conservation may signal the emergence of new flu strains. Proactive analysis of cross-conserved T cell epitopes may improve vaccine selection. Loss of T cell epitopes could also reduce the efficacy of new subclade K influenza vaccines in fall 2026.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.